Youxiang Ding
Impact in
-
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
-
- Flavonoids in Medical Research
- Pharmacological Effects of Natural Compounds
Papers in
-
- Signaling Pathways in Disease 2
- Hedgehog Signaling Pathway Studies 2
- Epigenetics and DNA Methylation 2
- RNA Research and Splicing 2
- FOXO transcription factor regulation 2
- Oncology 4
- Co-authors
- Li Zhao (11 shared papers)Qinglong Guo (8 shared papers)Yue Zhao (4 shared papers)Yang Sun (4 shared papers)You Zhou (4 shared papers)Ling‐Yi Kong (2 shared papers)Zhiyu Li (4 shared papers)Yan Liao (3 shared papers)
- Journals
- Oncotarget (2 papers)Journal of Cellular Physiology (2 papers)Molecular Carcinogenesis (1 paper)Life Sciences (1 paper)Cancers (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Youxiang Ding
16 papers receiving 395 citations
Peers
Comparison fields: 5 of 67
- Cancer Research 82
- Pharmacology 38
- Immunology and Allergy 22
- Molecular Biology 248
- Pharmacology 55
Countries citing papers authored by Youxiang Ding
This map shows the geographic impact of Youxiang Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Youxiang Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Youxiang Ding more than expected).
Fields of papers citing papers by Youxiang Ding
This network shows the impact of papers produced by Youxiang Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Youxiang Ding. The network helps show where Youxiang Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Youxiang Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 61 | |
| 2 | 2016 | 46 | |
| 3 | 2019 | 44 | |
| 4 | 2019 | 41 | |
| 5 | 2015 | 33 | |
| 6 | 2021 | 32 | |
| 7 | 2019 | 29 | |
| 8 | 2016 | 23 | |
| 9 | 2024 | 17 | |
| 10 | 2015 | 16 | |
| 11 | 2020 | 15 | |
| 12 | 2021 | 15 | |
| 13 | 2023 | 10 | |
| 14 | 2017 | 8 | |
| 15 | 2022 | 7 | |
| 16 | 2025 | 2 |
About Youxiang Ding
Youxiang Ding is a scholar working on Molecular Biology, Oncology, Immunology, Cancer Research and Genetics, having authored 16 papers that have together received 399 indexed citations. Recurring topics across this work include NF-κB Signaling Pathways (3 papers), Immune cells in cancer (3 papers), Signaling Pathways in Disease (2 papers), Hedgehog Signaling Pathway Studies (2 papers), Cell Adhesion Molecules Research (2 papers), Epigenetics and DNA Methylation (2 papers), RNA Research and Splicing (2 papers) and FOXO transcription factor regulation (2 papers). The work is most often cited by research in Cancer Research (82 citations), Pharmacology (38 citations), Immunology and Allergy (22 citations), Molecular Biology (248 citations) and Pharmacology (55 citations). Youxiang Ding has collaborated with scholars based in China and United States. Frequent co-authors include Li Zhao, Qinglong Guo, Yue Zhao, Yang Sun, You Zhou, Ling‐Yi Kong, Zhiyu Li, Yan Liao, Na Lu and Yue Yang. Their work appears in journals such as Oncotarget, Journal of Cellular Physiology, Molecular Carcinogenesis, Life Sciences and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.